Ken Fisher Aurinia Pharmaceuticals Inc. Transaction History

Fisher Asset Management, LLC

  • $247 Billion
  • Q2 2025

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 07, 2020
SELL
$14.12 - $18.33 $180,030 - $233,707
-12,750 Closed
0 $0
Q1 2020

Apr 28, 2020
BUY
$11.34 - $21.46 $144,585 - $273,615
12,750 New
12,750 $185,000

Others Institutions Holding AUPH

# of Institutions
242
Shares Held
61.9M
Call Options Held
1.02M
Put Options Held
668K
View Full List

About Aurinia Pharmaceuticals Inc.

AUPH Quotes by TradingView
  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.61B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track Ken Fisher's Portfolio

Track Ken Fisher Portfolio

Follow Ken Fisher (Fisher Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email